S 4120
117th Congress
Senate
Health
Cancer
Child health
Computers and information technology
Congressional oversight
Government studies and investigations
Health programs administration and funding
Health technology, devices, supplies
Medical research
Research administration and funding
Research and development
Childhood Cancer STAR Reauthorization Act
Everywhere this bill has been
18 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 5, 2023
Became Public Law No: 117-350.
Jan 5, 2023
Signed by President.
Dec 28, 2022
Presented to President.
Dec 22, 2022
Motion to reconsider laid on the table Agreed to without objection.
Dec 22, 2022
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H10025-10026)
Dec 22, 2022
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H10025-10026)
Dec 22, 2022
DEBATE - The House proceeded with forty minutes of debate on S. 4120.
Dec 22, 2022
Considered under suspension of the rules. (consideration: CR H10025-10026)
Dec 22, 2022
Mr. Pallone moved to suspend the rules and pass the bill.
Dec 21, 2022
Held at the desk.
Dec 21, 2022
Received in the House.
Dec 21, 2022
Message on Senate action sent to the House.
Dec 20, 2022
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S9613-9614)
Dec 20, 2022
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(text of amendment in the nature of a substitute: CR S9613-9614)
Dec 20, 2022
Measure laid before Senate by unanimous consent. (consideration: CR S9613-9614)
Dec 20, 2022
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
Apr 28, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2221)
Apr 28, 2022
Introduced in Senate
Plain-English summary
Childhood Cancer Survivorship, Treatment, Access, and Research Reauthorization Act of 2022 or the Childhood Cancer STAR Reauthorization Act
This act reauthorizes through FY2028 and modifies pediatric cancer research and related programs, including to expand collection of and access to relevant biospecimens and to support the transition of pediatric cancer survivors to primary care.
What's happening now
Became Public Law No: 117-350.
Committees of jurisdiction
1